{"schema_version":"secwatch.filing_event.v1","accession":"0001558370-22-012914","form_type":"8-K","ticker":"AZTA","cik":"0000933974","company_name":"Azenta, Inc.","filed_at":"2022-08-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:58.699071+00:00","generated_at":"2026-06-24T02:30:43.059265+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Azenta Q3 revenue $133M (+3% YoY); GAAP EPS -$0.09, non-GAAP $0.12","bullets":["Revenue $133M (+3% YoY); organic growth 6% despite FX headwind; Services up 6%, Products down 3%.","GAAP diluted EPS from continuing ops -$0.09; non-GAAP diluted EPS $0.12, flat sequentially.","Adjusted EBITDA $14M (10.4% margin), down 290 bps sequentially.","Completed Barkey acquisition for ~€80M; agreed to acquire B Medical for ~€410M, expected close Oct 2022.","Q4 FY22 guidance: revenue $131-141M, non-GAAP diluted EPS $0.04-$0.12."],"urls":{"canonical":"https://secwatch.observer/filing/0001558370-22-012914","json":"https://secwatch.observer/filing/0001558370-22-012914.json","markdown":"https://secwatch.observer/filing/0001558370-22-012914.md","text":"https://secwatch.observer/filing/0001558370-22-012914.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/933974/000155837022012914/0001558370-22-012914-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/933974/000155837022012914/azta-20220809x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-24T02:30:43.059265+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}